2019 | | Effect of Drug Adherence on Treatment Outcome in Rheumatoid Arthritis | 박범희 |
2021 | | Effectiveness and safety of biologic and targeted synthetic disease-modifying anti-rheumatic drugs in elderly patients with rheumatoid arthritis: Real-world data from the KOBIO registry | 김현아 |
2022 | | Efficacy of Abatacept Versus Tumor Necrosis Factor Inhibitors in Anti-citrullinated Protein Antibody-Positive Patients with Rheumatoid Arthritis: Results from a Korean Nationwide Biologics Registry | 김현아 |
2019 | | Evaluation of factors affecting the levels of physical activity in patients with rheumatoid arthritis: a cross-sectional study | 부선주, 서창희, 정주양 |
2022 | | Factors affecting quality of life in patients with rheumatoid arthritis in South Korea: a cross-sectional study | 김지원, 부선주, 서창희 |
2021 | | Four-year follow-up of atherogenicity in rheumatoid arthritis patients: from the nationwide Korean College of Rheumatology Biologics Registry | 김현아 |
2021 | | Health-related Quality of Life Outcomes of Adalimumab for Patients with Rheumatoid Arthritis in Korea | 김현아 |
2022 | | Implications of Persistent Pain in Patients With Rheumatoid Arthritis Despite Remission Status: Data From the KOBIO Registry | 김현아 |
2021 | | KOBIO, the first web-based Korean biologics registry operated with a unified platform among distinct disease entities | 김현아 |
2019 | | Long-term efficacy, safety and immunogenicity in patients with rheumatoid arthritis continuing on an etanercept biosimilar (LBEC0101) or switching from reference etanercept to LBEC0101: an open-label extension of a phase III multicentre, randomised, double-blind, parallel-group study | 서창희 |
1999 | | Open Clinical Trial of Methotrexate Alone and Combination of Methotrexate and Hydroxychloroquine in the Treatment of Rheumatoid Arthritis | 서창희 |
2020 | | Preclinical rheumatoid arthritis and rheumatoid arthritis prevention | 김현아 |
2014 | | Prediction for TNF Inhibitor Users in RA Patients According to Reimbursement Criteria Based on DAS28 | 김현아, 서창희 |
2018 | | Productivity Loss of Rheumatoid Arthritis Patients according to the Their Stages of the Disease Activity Score | 서창희 |
2018 | | Rapid onset of efficacy predicts response to therapy with certolizumab plus methotrexate in patients with active rheumatoid arthritis | 서창희 |
2023 | | Safety and Effectiveness of Etanercept Biosimilar SB4 for Rheumatic Diseases in South Korea: Real-World Post-marketing Surveillance Data | 서창희 |
2022 | | Study of the Expression and the Role of CMKLR1 in T cells of Patients with Rheumatoid Arthritis | 정은 |
2018 | | Transaminase Changes in Korean Rheumatoid Arthritis Patients with Chronic Hepatitis C after Biologic Therapy | 서창희 |
2023 | | Unveiling difficult-to-treat rheumatoid arthritis: long-term impact of biologic or targeted synthetic DMARDs from the KOBIO registry | 김지원, 김현아, 서창희, 정주양 |